daunorubicin has been researched along with Eye Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirmani, M; Minckler, DS; Patterson, R; Ryan, SJ; Santana, M; Sorgente, N; Wiedemann, P | 1 |
| Chen, EP; Hatchell, DL; Machemer, R; Steinhorst, UH | 1 |
| Cai, YS; Heimann, K; Hui, YN; Kirchhof, B; Liang, HC | 1 |
| Bishop, JF; Bradstock, K; Cobcroft, R; Enno, A; Fox, R; Garson, OM; Gillett, A; Herrmann, R; Joshua, D; Juneja, S; Lowenthal, RM; Matthews, JP; Page, F; Szer, J; Van Der Weyden, M; Wolf, MM; Young, GA | 1 |
| Chen, EP; Hatchell, DL; Saloupis, PT; Samsa, GP; Steinhorst, UH | 1 |
| Hatchell, DL; Khawly, JA; Machemer, R; Saloupis, P | 1 |
| Heimann, K; Hilgers, RD; Leinung, C; Wiedemann, P | 1 |
| Heimann, K; Lemmen, K; Schmiedl, R; Wiedemann, P | 1 |
| Heimann, K; Wiedemann, P | 1 |
| Bekhor, C; Patterson, R; Ryan, SJ; Sorgente, N; Tran, T; Wiedemann, P | 1 |
1 trial(s) available for daunorubicin and Eye Diseases
| Article | Year |
|---|---|
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Central Nervous System Diseases; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Eye Diseases; Female; Gastrointestinal Diseases; Humans; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Remission Induction; Survival Analysis; Treatment Outcome | 1996 |
9 other study(ies) available for daunorubicin and Eye Diseases
| Article | Year |
|---|---|
Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit.
Topics: Animals; Daunorubicin; Electroretinography; Eye Diseases; Female; Injections; Male; Microscopy, Electron; Rabbits; Retina; Retinal Diseases; Vitreous Body | 1984 |
Ocular toxicity of daunomycin: effects of subdivided doses on the rabbit retina after vitreous gas compression.
Topics: Animals; Dark Adaptation; Daunorubicin; Electroretinography; Eye Diseases; Female; Fluorocarbons; Male; Rabbits; Retinal Diseases; Vitreous Body | 1993 |
Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages.
Topics: Animals; Daunorubicin; Disease Models, Animal; Drug Carriers; Eye Diseases; Female; Injections; Liposomes; Macrophages; Male; Rabbits; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1993 |
The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy.
Topics: Animals; Daunorubicin; Disease Models, Animal; Drug Therapy, Combination; Eye Diseases; Female; Fibroblasts; Fundus Oculi; Male; Rabbits; Random Allocation; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1992 |
Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.
Topics: Animals; Cell Division; Daunorubicin; Disease Models, Animal; Drug Administration Schedule; Eye Diseases; Fibroblasts; Rabbits; Random Allocation; Retinal Detachment; Retinal Diseases; Vitreous Body | 1991 |
Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy.
Topics: Daunorubicin; Eye Diseases; Follow-Up Studies; Humans; Longitudinal Studies; Reoperation; Retinal Detachment; Retinal Diseases; Silicone Oils; Visual Acuity; Vitrectomy; Vitreous Body | 1991 |
Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy.
Topics: Daunorubicin; Eye Diseases; Eye Injuries; Humans; Retinal Diseases; Visual Acuity; Vitreous Body | 1987 |
[Proliferative vitreoretinopathy. Pathogenesis and possibilities for treatment with cytostatic drugs].
Topics: Antineoplastic Agents; Cell Division; Daunorubicin; Eye Diseases; Fluorouracil; Humans; Pigment Epithelium of Eye; Pyrimidines; Retinal Diseases; Vitreous Body | 1986 |
Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Effective doses in vitro and in vivo.
Topics: Animals; Autoradiography; Chromatography, High Pressure Liquid; Daunorubicin; Eye Diseases; Fibroblasts; In Vitro Techniques; Rabbits; Retinal Diseases; Spectrometry, Fluorescence; Vitreous Body | 1985 |